Article Information
- Received January 9, 2025
- Revision received June 21, 2025
- Accepted June 26, 2025
- Published online July 28, 2025.
Author Information
- Daniil Berezhnoi1,2,
- Hiba Douja Chehade1,2,
- Gabriel Simms3,
- Liqiang Chen1,2,
- Kishore Kumar S. Narasimhan4,
- Shashank M. Dravid4 and
- Hong-Yuan Chu1,2,*
- 1Department of Pharmacology and Physiology, Georgetown University of Medical Center, Washington DC, 20007, United States
- 2Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD, 20852, United States
- 3Department of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI 49503, United States
- 4Department of Psychiatry and Behavioral Sciences, Texas A&M Health Sciences Center, College of Medicine, Texas A&M University, College Station, TX 77845, United States
- ↵*Correspondence should be addressed to Hong-Yuan Chu at hc948{at}georgetown.edu
Author contributions
Author contributions: Conceptualization (DB, HYC); Investigation (DB, GS, HDC, LC, KKN); Formal analysis (DB, KKN, HYC); Validation (DB, LC, KKN, HYC); Writing – original draft (DB, HYC); Writing – Review & Editing (SMD, HYC); Supervision, Project administration and Funding acquisition (SMD, HYC).
Disclosures
Behavior recordings were conducted at the Van Andel Research Institute. Data analysis and manuscript preparation were performed and completed at Georgetown University Medical Center. This work was partially supported by research grants from the National Institutes of Health (R01NS121371, R21NS135545, H.Y.C; and R01NS133338, S.M.D. and H.Y.C.), Department of Defense Congressionally Directed Medical Research Programs (W81XWH-21-1-0943, H.Y.C.), and Parkinson’s Foundation (PF-IMP-1045313, H.Y.C.). This work was also funded in whole or in part by Aligning Science Across Parkinson’s (ASAP-020572) through the Michael J. Fox Foundation for Parkinson’s Research (MJFF). For the purpose of open access, the authors have applied a CC BY public copyright license to all Author Accepted Manuscripts arising from this submission.
Funding
HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
R01NS121371; R21NS135545; R01NS133338DOD | MHS | Congressionally Directed Medical Research Programs (CDMRP)
W81XWH-21-1-0943Parkinson's Foundation (PF)
PF-IMP-1045313Aligning Science Across Parkinson's (ASAP)
ASAP-020572
Article usage
In this issue
